FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

New Endpoint Option for Alcohol Use Disorder

CDER posts a drug development qualifying tool to support treatments for alcohol use disorder products.

Biologics

Clinical Hold on Moderna Norovirus Vaccine

FDA places a clinical hold on a Phase 3 study evaluating Modernas trivalent vaccine against norovirus (mRNA-1403) after a case of Guillain-Barr syndro...

latest-news-card-1
Biologics

FDA OKs Sanofis Merilog, a Novolog Biosimilar

FDA approves Sanofi-Aventis Merilog (insulin-aspart-szjj) as a biosimilar to Novo Nordisks Novolog (insulin aspart) for improving glycemic control in ...

latest-news-card-1
Medical Devices

Abiomed Recalls Impella Heart Pumps

Abiomed recalls its Impella RP with SmartAssist and Impella RP Flex with SmartAssist heart pumps to update their use instructions due to a risk that t...

latest-news-card-1
FDA General

Gender Statement Added to Restored FDA Pages

The Trump administration adds a gender ideology statement to two Web pages on draft guidances that FDA was ordered by a federal judge to restore earli...

Human Drugs

BMS Reports Disappointing Data in Melanoma Trial

Bristol Myers Squibb says a Phase 3 trial evaluating Opdualag (nivolumab and relatlimab-rmbw) for treating patients with completely resected stage III...

Human Drugs

More Accelerated Approval Changes Needed: Kaiser

The Kaiser Permanente healthcare system calls for FDA and congressional changes to improve the utility of the drug accelerated approval pathway.

latest-news-card-1
Human Drugs

Astellas Wins Revised Label for Izervay

FDA approves an Astellas Pharma supplemental NDA for Izervay (avacincaptad pegol intravitreal solution) that revises the labeling for the drugs use in...

latest-news-card-1
Human Drugs

Petition Seeks FDA Leukeran Actions

A Buchannan Ingersoll petition asks FDA to impose conditions on ANDAs for generic forms of the cancer drug Leukeran.

latest-news-card-1
Human Drugs

Endo Wants Generic Epinephrine Restrictions

Endo asks FDA not to receive or approve any applications for a generic form of Endos epinephrine products that do not refer to the Endo NDA.